Manufacturer record
Meg Lifesciences: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Meg Lifesciences (Himachal Pradesh) was declared Not of Standard Quality in August 2024. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: 7372, Amoxycillin & Potassium Clavulanate Tablets (Mexclav 625) (exp Sep 2025). CDL Kolkata (CDSCO lab) found it not of standard quality: Spurious Identification & Assay of Amoxycillin Trihydrate & Potassium Clavulanate. Listed in the August 2024 alert.
Records by type
1 record linked to Meg Lifesciences in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Amoxycillin & Potassium Clavulanate Tablets (Mexclav 625) | Batch 7372Mfg Oct 2023 · Exp Sep 2025 | Spurious Identification & Assay of Amoxycillin Trihydrate & Potassium ClavulanateAssay | CDL KolkataCDSCO lab | Aug 2024 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.